Governance Classic Home
BDH Industries LtdPharmaceuticalsINE278D01018
Valuation
Market Cap₹282.08 Cr
TTM PE24.09x
Forward PE23.27x
PEG0.80
Book Value₹105.82
P/B4.63x
TTM EPS₹20.34
Fwd EPS₹21.05
TTM Revenue₹99.71 Cr
TTM PAT₹11.71 Cr
TTM EBITDA₹15.23 Cr
TTM EBIT₹14.36 Cr
Last Qtr PAT₹2.88 Cr
Last Qtr EBITDA₹3.47 Cr
Last Qtr EBIT₹3.26 Cr
Profitability
ROE—
ROCE—
TTM NPM11.74%
TTM EBITDA %15.27%
Curr OPM12.17%
Last OPM9.92%
Curr NPM—
Last NPM—
Curr EPS₹4.73
Last EPS₹5.00
Balance sheet
Equity—
Reserve—
Total Debt₹0.00 Cr
D/E—
Interest %0.37%
Curr Interest₹0.01 Cr
Price / range
Close₹489.95
vs 52W High-19.68%
vs 52W Low+44.04%
MA50—
MA200—
Returns
1D-2.58%
1W-4.07%
1M-9.27%
3M+11.63%
6M+22.49%
1Y+13.05%
2Y+38.87%
3Y+175.25%
5Y+308.46%
Diwali+16.38%
Sector peers — Pharmaceuticals
CompanyCloseMkt CapTTM P/EROE
SUNPHARMA1868.90₹4.48L Cr150.723.58%
DIVISLAB9410.50₹2.50L Cr84.9417.55%
TORNTPHARM4970.00₹1.89L Cr80.9225.43%
ZYDUSLIFE1161.00₹1.16L Cr33.2412.96%
CIPLA1386.10₹1.12L Cr36.428.93%
LAURUSLABS2017.50₹1.09L Cr124.8516.46%
MANKIND2437.80₹1.01L Cr46.1413.38%
DRREDDY1198.30₹1.00L Cr150.351.75%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Standalone

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue22.38+20.2%29.0329.3418.9618.6295.96
Other Income0.450.610.530.550.552.24
Total Income22.82+19.0%29.6529.8719.5119.1798.20
Interest0.010.010.010.030.010.06
Expenditure-19.13-14.6%-25.06-25.34-15.88-16.70-83.01
PBDT000000
EBITDA3.47+61.4%4.204.233.332.1513.88
Depreciation-0.21-0.22-0.22-0.22-0.22-0.87
EBIT3.26+68.9%3.984.013.111.9313.01
PBT3.70+51.6%4.594.533.632.4415.19
Tax-0.97-1.71-1.04-1.02-0.60-4.38
Equity000000
OPM16.5115.8115.4419.1713.1115.00
Net Profit2.72+48.6%2.883.492.621.8310.81
NPM12.179.9211.8913.819.8111.00
EPS4.7356.064.55018.78

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue95.96+44.3%66.51-22.5%85.83+15.3%74.46+7.3%69.39+20.8%57.45
Other Income2.241.841.580.840.881.30
Total Income98.20+43.7%68.35-21.8%87.41+16.1%75.30+7.1%70.28+19.6%58.76
Expenditure-83.01-48.8%-55.80+24.8%-74.16-15.5%-64.23-5.0%-61.17-22.3%-50.01
Interest-0.06-0.07-0.18-0.16-0.23-0.28
PBDT000000
EBITDA13.88+18.7%11.69-6.0%12.43+13.4%10.96+20.7%9.08+6.7%8.51
Depreciation-0.87-0.91-0.58-0.57-0.63-0.79
EBIT13.01+20.7%10.78-9.0%11.85+14.1%10.39+23.0%8.45+9.5%7.72
PBT15.19+21.8%12.47-5.9%13.25+19.7%11.07+15.9%9.55+9.1%8.75
Tax-4.38-3.10-3.38-2.86-2.33-2.39
Equity000000
OPM (%)15.0018.0015.0015.0014.0015.00
Net Profit10.81+16.6%9.27-6.1%9.87+20.2%8.21+13.7%7.22+13.5%6.36
NPM (%)11.0014.0011.0011.0010.0011.00
EPS (Rs)18.78+16.6%16.11-6.0%17.14+20.3%14.25+13.5%12.55+13.6%11.05
CEPS18.7816.1117.1414.2512.5511.05

Consolidated

0 lines · 0 periods

No financial result data.

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

0 lines · 0 years

No yearly result data.

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

17
YearTypeAmountEx-Date
2026Final Dividend507 Aug 2026
2025Final Dividend4.501 Aug 2025
2024Final Dividend4.502 Aug 2024
2023Final Dividend402 Aug 2023
2022Final Dividend3.612 Aug 2022
2021Final Dividend317 Aug 2021
2020Final Dividend2.519 Aug 2020
2019Final Dividend2.7509 Sep 2019
2018Final Dividend2.2517 Sep 2018
2017Final Dividend219 Sep 2017
2016Final Dividend214 Sep 2016
2015Final Dividend1.418 Sep 2015
2015Special Dividend0.318 Sep 2015
2014Final Dividend1.209 Sep 2014
2013Final Dividend121 Aug 2013
2012Final Dividend0.620 Sep 2012
2011Final Dividend0.520 Sep 2011

Bonus

0

No bonus history.

Split

0

No split history.

Loading company dashboard...
Fetching ratios, charts, and peers